Literature DB >> 16790811

Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes.

Lea Barfod1, Morten A Nielsen, Louise Turner, Madeleine Dahlbäck, Anja T R Jensen, Lars Hviid, Thor G Theander, Ali Salanti.   

Abstract

We raised specific antisera against recombinant VAR2CSA domains produced in Escherichia coli and in insect cells. All were reactive in enzyme-linked immunosorbent assay, but only insect cell-derived constructs induced immunoglobulin G (IgG) that was reactive with native VAR2CSA on the surface of infected erythrocytes. Our data show that five of the six VAR2CSA Duffy-binding-like domains are surface exposed and that induction of surface-reactive VAR2CSA-specific IgG depends critically upon antigen conformation. These findings have implications for the development of vaccines against pregnancy-associated Plasmodium falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790811      PMCID: PMC1489712          DOI: 10.1128/IAI.01617-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria.

Authors:  D Dodoo; M Theisen; J A Kurtzhals; B D Akanmori; K A Koram; S Jepsen; F K Nkrumah; T G Theander; L Hviid
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

2.  Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses.

Authors:  R E Smith; A M Donachie; D Grdic; N Lycke; A M Mowat
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

3.  A retrospective review of lesions associated with the use of Freund's adjuvant.

Authors:  J R Broderson
Journal:  Lab Anim Sci       Date:  1989-09

Review 4.  Aluminium compounds for use in vaccines.

Authors:  Erik B Lindblad
Journal:  Immunol Cell Biol       Date:  2004-10       Impact factor: 5.126

Review 5.  Use of CpG oligodeoxynucleotides as immune adjuvants.

Authors:  Dennis M Klinman; Debra Currie; Ihsan Gursel; Daniela Verthelyi
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

6.  Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.

Authors:  Trine Staalsoe; Caroline E Shulman; Judith N Bulmer; Ken Kawuondo; Kevin Marsh; Lars Hviid
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

7.  Genome sequence of the human malaria parasite Plasmodium falciparum.

Authors:  Malcolm J Gardner; Neil Hall; Eula Fung; Owen White; Matthew Berriman; Richard W Hyman; Jane M Carlton; Arnab Pain; Karen E Nelson; Sharen Bowman; Ian T Paulsen; Keith James; Jonathan A Eisen; Kim Rutherford; Steven L Salzberg; Alister Craig; Sue Kyes; Man-Suen Chan; Vishvanath Nene; Shamira J Shallom; Bernard Suh; Jeremy Peterson; Sam Angiuoli; Mihaela Pertea; Jonathan Allen; Jeremy Selengut; Daniel Haft; Michael W Mather; Akhil B Vaidya; David M A Martin; Alan H Fairlamb; Martin J Fraunholz; David S Roos; Stuart A Ralph; Geoffrey I McFadden; Leda M Cummings; G Mani Subramanian; Chris Mungall; J Craig Venter; Daniel J Carucci; Stephen L Hoffman; Chris Newbold; Ronald W Davis; Claire M Fraser; Bart Barrell
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

8.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.

Authors:  Ali Salanti; Trine Staalsoe; Thomas Lavstsen; Anja T R Jensen; M P Kordai Sowa; David E Arnot; Lars Hviid; Thor G Theander
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

9.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

10.  Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes.

Authors:  Anja T R Jensen; Pamela Magistrado; Sarah Sharp; Louise Joergensen; Thomas Lavstsen; Antonella Chiucchiuini; Ali Salanti; Lasse S Vestergaard; John P Lusingu; Rob Hermsen; Robert Sauerwein; Jesper Christensen; Morten A Nielsen; Lars Hviid; Colin Sutherland; Trine Staalsoe; Thor G Theander
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

View more
  40 in total

1.  Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.

Authors:  Mirja Hommel; Salenna R Elliott; Viju Soma; Greg Kelly; Freya J I Fowkes; Joanne M Chesson; Michael F Duffy; Joseph Bockhorst; Marion Avril; Ivo Mueller; Andrew Raiko; Danielle I Stanisic; Stephen J Rogerson; Joseph D Smith; James G Beeson
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

2.  Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malaria.

Authors:  Lester H Lambert; Jeanee L Bullock; Sharma T Cook; Kazutoyo Miura; David N Garboczi; Mahamadou Diakite; Rick M Fairhurst; Kavita Singh; Carole A Long
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA.

Authors:  Morten A Nielsen; Vera V Pinto; Mafalda Resende; Madeleine Dahlbäck; Sisse B Ditlev; Thor G Theander; Ali Salanti
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

4.  Pregnancy malaria: cryptic disease, apparent solution.

Authors:  Patrick Emmet Duffy; Michal Fried
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

5.  An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype.

Authors:  Inès Vigan-Womas; Micheline Guillotte; Cécile Le Scanf; Sébastien Igonet; Stéphane Petres; Alexandre Juillerat; Cyril Badaut; Farida Nato; Achim Schneider; Anne Lavergne; Hugues Contamin; Adama Tall; Laurence Baril; Graham A Bentley; Odile Mercereau-Puijalon
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

6.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

7.  Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA.

Authors:  Lea Barfod; Nadia L Bernasconi; Madeleine Dahlbäck; David Jarrossay; Pernille Haste Andersen; Ali Salanti; Michael F Ofori; Louise Turner; Mafalda Resende; Morten A Nielsen; Thor G Theander; Federica Sallusto; Antonio Lanzavecchia; Lars Hviid
Journal:  Mol Microbiol       Date:  2006-12-14       Impact factor: 3.501

8.  Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris.

Authors:  Marion Avril; Marianne J Hathaway; Megan M Cartwright; Severin O Gose; David L Narum; Joseph D Smith
Journal:  Malar J       Date:  2009-06-29       Impact factor: 2.979

9.  The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs.

Authors:  Lars M Joergensen; Ali Salanti; Tina Dobrilovic; Lea Barfod; Tue Hassenkam; Thor G Theander; Lars Hviid; David E Arnot
Journal:  Malar J       Date:  2010-04-19       Impact factor: 2.979

10.  Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies.

Authors:  Ali Salanti; Mafalda Resende; Sisse B Ditlev; Vera V Pinto; Madeleine Dahlbäck; Gorm Andersen; Tom Manczak; Thor G Theander; Morten A Nielsen
Journal:  Malar J       Date:  2010-01-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.